Homology Medicines, Inc. (FIXX) earnings
Quarterly and annual FIXX reports and results, each read against the price at its own news timestamp. Back to the FIXX overview →
3 measured FIXX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K Homology Medicines, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.06% | |
| Form 10-Q Homology Medicines, Inc. For: Sep 30 | SEC filing · Form 10-Q | -5.19% | -9.87% | |
| Homology Medicines Reports Third Quarter 2023 Financial Results | Press release | -5.19% | -9.87% |
Keep exploring
More FIXX: analyst actions → · SEC filings → · FIXX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MEDICAL IMAGING CORP (MEDD) | 81 | 0.00% | 32% |
| TRACON PHARMS INC (TCON) | 81 | -0.63% | 16% |
| Orchard Therapeutics plc - American Depositary Shares (ORTX) | 80 | +0.06% | 66% |
| Elite Pharmaceuticals, Inc. (ELTP) | 79 | -0.11% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.